Anglais

Sample ID, body site where sample was obtained, analyte type, and tumor status of samples of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.

6 Formulaires  
  1. StudyEvent: SEV1
    1. Subject ID, case or control, age, gender, country of birth, BMI, waist of hip ratio, plasma cholesterol, plasma triglycerides, total plasma high density lipoprotein cholesterol, systolic and diastolic blood pressure, smoking, fasting glucose, 120 minute post-load glucose, age at diabetes diagnosis, presence of diabetic retinopathy, glycosylated hemoglobin, serum creatinine, albumin, impaired fasting glucose, Impaired glucose tolerance, and fasting insulin of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    2. Subject ID, consent group, affection status, subject source, and source subject ID of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    3. Subject ID, sample ID, sample source, source sample ID, study ID, and sample use variable obtained from participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    4. Subject ID, gender, age, T2D status, age at diagnosis of diabetes, fasting glucose and insulin, glucose, HbA1C, creatinine, total cholesterol, HDL, triglycerides, height, weight, BMI, hip circumference, waist circumference, systolic blood pressure, diastolic blood pressure, lipid medication, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    5. Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of sample obtained from participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    6. Sample ID, body site where sample was obtained, analyte type, and tumor status of samples of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
pht005635
Description

pht005635

Alias
UMLS CUI [1,1]
C3846158
De-identified Sample ID
Description

SAMPID

Type de données

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C1299222
Body site where sample was collected
Description

BODY_SITE

Type de données

string

Alias
UMLS CUI [1,1]
C0449705
Analyte Type
Description

ANALYTE_TYPE

Type de données

string

Alias
UMLS CUI [1,1]
C4744818
Tumor status
Description

IS_TUMOR

Type de données

text

Alias
UMLS CUI [1,1]
C0475752
Retour au début de la page

Similar models

Sample ID, body site where sample was obtained, analyte type, and tumor status of samples of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.

6 Formulaires
  1. StudyEvent: SEV1
    1. Subject ID, case or control, age, gender, country of birth, BMI, waist of hip ratio, plasma cholesterol, plasma triglycerides, total plasma high density lipoprotein cholesterol, systolic and diastolic blood pressure, smoking, fasting glucose, 120 minute post-load glucose, age at diabetes diagnosis, presence of diabetic retinopathy, glycosylated hemoglobin, serum creatinine, albumin, impaired fasting glucose, Impaired glucose tolerance, and fasting insulin of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    2. Subject ID, consent group, affection status, subject source, and source subject ID of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    3. Subject ID, sample ID, sample source, source sample ID, study ID, and sample use variable obtained from participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    4. Subject ID, gender, age, T2D status, age at diagnosis of diabetes, fasting glucose and insulin, glucose, HbA1C, creatinine, total cholesterol, HDL, triglycerides, height, weight, BMI, hip circumference, waist circumference, systolic blood pressure, diastolic blood pressure, lipid medication, consortium name, and cohort name of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    5. Sample ID, body site where sample was obtained, analyte type, histological type of sample, sequencing center, and tumor status of sample obtained from participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
    6. Sample ID, body site where sample was obtained, analyte type, and tumor status of samples of participants with or without T2D and involved in the "Type 2 Diabetes Starr County GWAS and Exome Sequencing" project.
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
pht005635
C3846158 (UMLS CUI [1,1])
SAMPID
Item
De-identified Sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYTE_TYPE
Item
Analyte Type
string
C4744818 (UMLS CUI [1,1])
Item
Tumor status
text
C0475752 (UMLS CUI [1,1])
IS_TUMOR
Code List
Tumor status
CL Item
Is not a tumor (N)
C0027651 (UMLS CUI [1,1])
C1518422 (UMLS CUI [1,2])
CL Item
Is tumor (Y)
C0027651 (UMLS CUI [1,1])
Retour au début de la page